Astellas Pharma
Connections
Around the web
-
Lesley Visser to Speak at Astellas Presents Executive Women's Day at the Crowne Plaza Invitational at Colonial
community." About Astellas Astellas Pharma US, Inc., located in Northbrook, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision 5/20/13 from PR Newswire Read more »
-
Accelerate LI’s Lofty Goal: Create the Next U.S. Innovation Cluster
Astellas Pharma shuttered the labs of OSI Pharmaceuticals last week, no one felt that loss as acutely as the residents of Long Island, NY. OSI, famed for its lung cancer drug erlotinib (Tarceva), had shown that it was possible to create a large pharmaceutical from Xconomy Read more »
-
AstraZeneca PLC, Cubist Pharmaceuticals, Inc., Astellas Pharma Inc. Said to Make Bids for Optimer Pharmaceuticals, Inc.
surged 14 percent. The maker of the Dificid drug used to treat intestinal infections also attracted an offer from Japan’s Astellas Pharma Inc. (4503) and others, said the people, who asked not to be named because the process is private. Optimer’s managers from Biospace Read more »
-
FDA Approves TARCEVA (ERLOTINIB) Tablets and COBAS EGFR MUTATION TEST for Specific Type of Ling Cancer
to be an award recipient of the CEO Gold Standard Accreditation from the CEO Roundtable on Cancer. For more information on Astellas Pharma Inc., please visit our website at http://www.astellas.us. Founded more than 30 years ago, Genentech is a leading biotechnology from Check Orphan Read more »
-
Astellas Pharma Inc. Shuts Down OSI Pharmaceuticals, Inc., Perseid in Restructuring of R&D Ops, Cuts 200 Jobs
today! Reshaping Research Framework to Enhance the Ability to Generate Innovative Drugs Tokyo, Japan, May 14, 2013 - Astellas Pharma Inc. (Tokyo:4503, President and CEO: Yoshihiko Hatanaka, hereinafter called "Astellas") today announced plans to reshape its from Biospace Read more »
